Hollywood’s upper crust has converged on Venice for the three-day wedding extravaganza of Amazon mogul Jeff Bezos and Lauren Sanchez, with a cluster of snatched

A federal judge said the government did not run afoul of the law when it required Johnson & Johnson to seek approval before implementing its

Novo Nordisk NVO and Eli Lilly LLY dominate the diabetes and obesity market on the back of the tremendous success of their GLP-1 products. Novo Nordisk markets its semaglutide

With a first-in-class approval in China, Eli Lilly’s GLP-1 development engine has delivered yet again on the obesity front—although local biopharma outfit Innovent Biologics will

Imagine getting rid of your persistent fat layers, while gaining girth down under. That’s a contemporary equivalent to the fabled fountain of youth, and a

Amgen AMGN is one of the several drug makers racing to develop the next blockbuster weight loss drug and take a share of the booming weight

Post Content

GLP-1 drugs, such as Ozempic, are reshaping diabetes care and weight loss. Find out if Medicare covers them and if they’re right for you.

Innovent said on Friday that its obesity medicine mazdutide has been approved in China, becoming the first dual GLP-1/glucagon agonist to be greenlit for the

GLP-1 drugs, which have seen widespread success, have been linked to a number of cases of pancreatitis in the UK, which have led to hospitalisations

And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal

A NEW weight loss jab that only needs to be taken once monthly leads to “substantial weight loss”, according to early trials. Drugs like Wegovy

Shares in Amylyx Pharmaceuticals (NASDAQ: AMLX) were up almost 28% in the week to Friday morning. The move comes after an analyst at Guggenheim initiated

Shares in Amylyx Pharmaceuticals (NASDAQ: AMLX) were up almost 28% in the week to Friday morning. The move comes after an analyst at Guggenheim initiated

Novo Nordisk’s Pricing Crossroads: Regulatory Risks and Competitive Pressures Threaten GLP-1 Dominance  AInvest

A WOMAN has revealed that thanks to Mounjaro, she has lost eight stone and has dropped from a size 20 to an 8. But Alexandra,

Semaglutide is linked to a reduced risk for Alzheimer’s disease-related dementia in patients with diabetes vs other antidiabetic drugs, a new study suggests. Medscape Medical

Weight-loss drugs are this decade’s blockbuster medicines. Drugs like Ozempic, Wegovy, and Mounjaro help people with diabetes get their blood sugar under control and help

Since the GLP-1 drugs, including Mounjaro, Ozempic and Wegovy, were licensed, there have been hundreds of reported cases of acute and chronic pancreatitis among people

Some cases of pancreatitis have been reported to be linked to GLP-1 medicines. Here’s what we know

Women on Mounjaro may miss signs of pancreatitis. Learn the symptoms, risks, and what UK health authorities are doing to monitor GLP-1 weight loss drugs.

The weight-loss injection boom that swept through Hollywood and boardrooms alike is now facing a potentially deadly reckoning. The UK’s Medicines and Healthcare products Regulatory

The United Kingdom’s health regulator is investigating weight loss jabs like Ozempic and Mounjaro after linking it to hundreds of severe illnesses and even a

GLP-1 has become a hot topic in health and wellness. If you’ve heard of medications like Ozempic or Wegovy, then you’ve already heard about GLP-1.

The UK’s MHRA and Genomics England have launched a groundbreaking study to investigate whether genetics play a role in developing acute pancreatitis after taking GLP-1

What does the fracturing of vaccine advice and policy mean for the U.S. health care ecosystem? Will the potential head of the Centers for Disease

This week German startup Climatiq secured $11.7m to embed carbon intelligence into daily business operations and Turkish farm digitization startup Doktar secured $8.8m to expand

Viking Therapeutics VKTX announced that it has initiated the phase III VANQUISH program, evaluating the subcutaneous (SC) formulation of its experimental obesity drug VK2735 in adult

Weight loss and diabetes jabs taken by more than a million people in Britain have been linked to a potential serious side effect, with some

GLP-1 agonists were linked to greater risk for neovascular age-related macular degeneration.

After three years, only about 1 in 12 individuals taking GLP-1s to treat obesity remained on the therapy, according to a Prime Therapeutics study published

Eli Lilly LLY has experienced significant growth in the past few years, particularly driven by the success of its popular tirzepatide injections, Mounjaro for type

Merck MRK has built a substantial portfolio of new products and pipeline candidates in areas like oncology, vaccines, neuroscience, and infectious disease. Merck’s phase III pipeline

Over 100 cases of acute pancreatitis have been reported to UK health regulators this year, many tied to the newest GLP-1 drug on the market.

There are serious potential side effects to GLP-1 weight-loss drugs. This episode features audio from: https://nutritionfacts.org/video/is-ozempic-semaglutide-safe-does-it-increase-cancer-risk/ Visit the video page for all sources and doctor’s

Drs. Idries and Jamil Abdur-Rahman answer medical questions about the health effects of drinking instant coffee, the possibility of GLP-1 medications increasing the risk of

It’s taken me a couple of months to get to this but a reader in Montreal wanted to be sure I did not miss this

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Today, we uncover the